These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 15367050

  • 21. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs.
    Brouwer JMJL, Nijenhuis M, Soree B, Guchelaar HJ, Swen JJ, van Schaik RHN, Weide JV, Rongen GAPJM, Buunk AM, de Boer-Veger NJ, Houwink EJF, van Westrhenen R, Wilffert B, Deneer VHM, Mulder H.
    Eur J Hum Genet; 2022 Oct; 30(10):1114-1120. PubMed ID: 34782755
    [Abstract] [Full Text] [Related]

  • 22. Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index.
    Gentile S.
    Drug Saf; 2007 Oct; 30(2):107-21. PubMed ID: 17253877
    [Abstract] [Full Text] [Related]

  • 23. Impact of CYP2D6 Genotype on Paroxetine Serum Concentration.
    Hole K, Haslemo T, Molden E.
    Ther Drug Monit; 2023 Oct 01; 45(5):683-688. PubMed ID: 37012633
    [Abstract] [Full Text] [Related]

  • 24. Short-Term Safety of Paroxetine Plus Low-Dose Mirtazapine During Lactation.
    Uguz F.
    Breastfeed Med; 2019 Mar 01; 14(2):131-132. PubMed ID: 30489153
    [Abstract] [Full Text] [Related]

  • 25. Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine.
    Scordo MG, Spina E, Dahl ML, Gatti G, Perucca E.
    Basic Clin Pharmacol Toxicol; 2005 Nov 01; 97(5):296-301. PubMed ID: 16236141
    [Abstract] [Full Text] [Related]

  • 26. Citalopram in pregnancy and lactation.
    Heikkinen T, Ekblad U, Kero P, Ekblad S, Laine K.
    Clin Pharmacol Ther; 2002 Aug 01; 72(2):184-91. PubMed ID: 12189365
    [Abstract] [Full Text] [Related]

  • 27. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH.
    Clin Pharmacokinet; 1997 Aug 01; 32 Suppl 1():1-21. PubMed ID: 9068931
    [Abstract] [Full Text] [Related]

  • 28. Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.
    van der Weide J, van Baalen-Benedek EH, Kootstra-Ros JE.
    Ther Drug Monit; 2005 Aug 01; 27(4):478-83. PubMed ID: 16044105
    [Abstract] [Full Text] [Related]

  • 29. Sertraline and breastfeeding: review and meta-analysis.
    Pinheiro E, Bogen DL, Hoxha D, Ciolino JD, Wisner KL.
    Arch Womens Ment Health; 2015 Apr 01; 18(2):139-146. PubMed ID: 25589155
    [Abstract] [Full Text] [Related]

  • 30. Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine.
    McAlpine DE, Biernacka JM, Mrazek DA, O'Kane DJ, Stevens SR, Langman LJ, Courson VL, Bhagia J, Moyer TP.
    Ther Drug Monit; 2011 Feb 01; 33(1):14-20. PubMed ID: 21099743
    [Abstract] [Full Text] [Related]

  • 31. Sertraline, citalopram and paroxetine in lactation: passage into breastmilk and infant exposure.
    Den Besten-Bertholee D, Touw DJ, Damer EA, Mian P, Ter Horst PGJ.
    Front Pharmacol; 2024 Feb 01; 15():1414677. PubMed ID: 38841362
    [Abstract] [Full Text] [Related]

  • 32. Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator.
    Jornil J, Jensen KG, Larsen F, Linnet K.
    Drug Metab Dispos; 2010 Mar 01; 38(3):376-85. PubMed ID: 20007670
    [Abstract] [Full Text] [Related]

  • 33. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.
    Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, Singh AB, Ruaño G, Mueller DJ, Tsermpini EE, Brown JT, Bell GC, Leeder JS, Gaedigk A, Scott SA, Klein TE, Caudle KE, Bishop JR.
    Clin Pharmacol Ther; 2023 Jul 01; 114(1):51-68. PubMed ID: 37032427
    [Abstract] [Full Text] [Related]

  • 34. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.
    Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee KH, Skaar T, Storniolo AM, Li L, Araba A, Blanchard R, Nguyen A, Ullmer L, Hayden J, Lemler S, Weinshilboum RM, Rae JM, Hayes DF, Flockhart DA.
    J Natl Cancer Inst; 2005 Jan 05; 97(1):30-9. PubMed ID: 15632378
    [Abstract] [Full Text] [Related]

  • 35. Evidence for involvement of polymorphic CYP2C19 and 2C9 in the N-demethylation of sertraline in human liver microsomes.
    Xu ZH, Wang W, Zhao XJ, Huang SL, Zhu B, He N, Shu Y, Liu ZQ, Zhou HH.
    Br J Clin Pharmacol; 1999 Sep 05; 48(3):416-23. PubMed ID: 10510155
    [Abstract] [Full Text] [Related]

  • 36. Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors.
    Spigset O, Hedenmalm K, Dahl ML, Wiholm BE, Dahlqvist R.
    Acta Psychiatr Scand; 1997 Nov 05; 96(5):379-84. PubMed ID: 9395157
    [Abstract] [Full Text] [Related]

  • 37. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.
    Ereshefsky L, Riesenman C, Lam YW.
    Clin Pharmacokinet; 1995 Nov 05; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618
    [Abstract] [Full Text] [Related]

  • 38. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine.
    Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K.
    Eur J Clin Pharmacol; 1996 Nov 05; 51(1):73-8. PubMed ID: 8880055
    [Abstract] [Full Text] [Related]

  • 39. Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques.
    Delaney SR, Malik PRV, Stefan C, Edginton AN, Colantonio DA, Ito S.
    Clin Pharmacokinet; 2018 Dec 05; 57(12):1603-1611. PubMed ID: 29651785
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.
    Wang JH, Liu ZQ, Wang W, Chen XP, Shu Y, He N, Zhou HH.
    Clin Pharmacol Ther; 2001 Jul 05; 70(1):42-7. PubMed ID: 11452243
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.